Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Gen Digital Inc

GEN
28,26
-1,12 (-3,81%)
19 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202423:25PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
10/12/202422:08EDGAR2Form 425 - Prospectuses and communications, business..
10/12/202414:13EDGAR2Form 425 - Prospectuses and communications, business..
10/12/202414:11EDGAR2Form 8-K - Current report
10/12/202414:00PRNUSGen Extends its Financial Wellness Offerings with the..
04/12/202415:00PRNUSGen Reveals Cybersecurity Predictions for 2025
03/12/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:15EDGAR2Form 144 - Report of proposed sale of securities
21/11/202417:30PRNUSNorton Introduces Small Business Premium for Powerful,..
19/11/202415:00PRNUSGen Q3 Threat Report: Millions Fooled by "Scam-Yourself..
06/11/202417:01GLOBEGenmab Announces Financial Results for the First Nine Months..
31/10/202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/10/202421:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202421:05EDGAR2Form 8-K - Current report
30/10/202421:05PRNUSGen Reports Second Quarter Fiscal Year 2025 Results
29/10/202408:01PRNUSDon't Let Scammers Steal Your Holiday Cheer: New Norton..
17/10/202422:00PRNUSElection Scams on the Rise: Over Half of Americans Targeted..
15/10/202412:25GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
08/10/202422:05PRNUSGen to Announce Fiscal 2025 Second Quarter Results on..
04/10/202419:55GLOBEMajor Shareholder Announcement
24/9/202417:00PRNUSNorton Benefit Solutions Expands Global Offering
19/9/202414:00PRNUSAARP Services Announces New Enhanced Offerings for AARP..
13/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:16EDGAR2Form 8-K - Current report
13/9/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
13/9/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202415:00PRNUSMulti-million-dollar Deepfake Campaigns Blocked by Gen
21/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202415:00PRNUSParents Cautiously Optimistic on AI in Schools: Content..
20/8/202400:09EDGAR2Form 144 - Report of proposed sale of securities
19/8/202420:00GLOBETEPKINLY® (epcoritamab) Receives Second European Commission..
08/8/202417:03GLOBEGenmab Announces Financial Results for the First Half of..
08/8/202417:00GLOBEGenmab Updates 2024 Financial Guidance
06/8/202415:00PRNUSNew LifeLock Scan Tool Reveals Our Data is 'Out of Control'
05/8/202411:50GLOBEGenmab Takes Full Control of Acasunlimab Development Program
01/8/202422:05EDGAR2Form 8-K - Current report
01/8/202422:05PRNUSGen Reports First Quarter Fiscal Year 2025 Results
30/7/202418:00PRNUSNew Norton VPN Lineup Delivers Ultra Protection
29/7/202414:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
Apertura: 29,50 Min: 27,71 Max: 29,50
Chiusura: 29,38

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network